Basics Penumbra, Inc. Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. IPO Date: September 18, 2015 Sector: Healthcare Industry: Medical Devices Market Cap: $11.77B Activated in VL: True Average Daily Range Avg Daily Range: $3.07 | 1.78% Avg Daily Range (30 D): $4.14 | 1.56% Avg Daily Range (90 D): $3.42 | 1.31% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 49 Avg Trade Size (Sh.) (30 D): 26 Avg Trade Size (Sh.) (90 D): 29 Institutional Trades Total Inst.Trades: 3,817 Avg Inst. Trade: $6.03M Avg Inst. Trade (30 D): $11.1M Avg Inst. Trade (90 D): $12.08M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $7.76M Avg Closing Trade (30 D): $16.87M Avg Closing Trade (90 D): $16.58M Avg Closing Volume: 38.4K     News Nov 9, 2025 @ 12:08 PM Expedia, Sandisk and Penumbra Are Among the Top 10... Source: Nabaparna Bhattacharya Apr 24, 2025 @ 7:27 PM Penumbra Among Well-Insulated Companies From Ongoi... Source: Vandana Singh Nov 1, 2024 @ 12:00 PM Exploring the Future of Virtual Reality: Market Ov... Source: N/A Oct 14, 2024 @ 10:20 PM Why Penumbra Stock Zoomed 4% Higher Today Source: Eric Volkman Sep 18, 2024 @ 10:29 PM Why Penumbra Stock Zoomed Nearly 5% Higher Today Source: Eric Volkman Financials   TTM Q3 2025 Q2 2025 Basic EPS $4.23 $1.17 $1.17 Diluted EPS $4.19 $1.17 $1.15 Revenue $ 1.33B $ 354.69M $ 339.46M Gross Profit $ 891.03M $ 240.42M $ 224.01M Net Income / Loss $ 164.03M $ 45.85M $ 45.27M Operating Income / Loss $ 172.79M $ 48.84M $ 40.83M Cost of Revenue $ 442.77M $ 114.27M $ 115.45M Net Cash Flow $ 40.55M $ -100.74M $ 45.71M PE Ratio 70.29